Illumina appeals FTC order to divest cancer test maker Grail

San Diego-based Illumina is arguing that the FTC "violated due process by depriving Illumina and Grail of a fair proceeding before an impartial tribunal," according to the filing in the U.S. Fifth Circuit Court of Appeals.ruled for a second time

The FTC has been concerned that Illumina, the dominant provider of DNA sequencing of tumors and cancer cells that help match patients with the best treatment option, might raise prices or refuse to sell to Grail's rivals. Illumina has pledged to continue selling its DNA sequencing services to other firms. It has offered to sign contracts to supply any of Grail's rivals and to not raise prices.In early December, EU antitrust regulators proposed measures for Illumina to unwind its acquisition of Grail, three months after blocking the deal.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bay Area biotech firm Grail wrongly told hundreds of people they might have cancerGrail, a biotech firm that makes a blood test for detecting cancer, blamed the snafu on a technology glitch.
Source: KPIXtv - 🏆 443. / 53 Read more »

Hundreds mistakenly told they might have cancer, test company Grail saysHundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday.
Source: ABC7Chicago - 🏆 284. / 63 Read more »

Hundreds mistakenly told they might have cancer, test company Grail saysHundreds of people using the test company Grail, based in Menlo Park, were wrongly told they might have cancer, the company said in a statement Monday.
Source: abc7newsbayarea - 🏆 529. / 51 Read more »

Hundreds mistakenly told they might have cancer, test company Grail saysHundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday.
Source: 6abc - 🏆 250. / 63 Read more »